Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-04-10 | CORCEPT THERAPEUTICS INC | MAHONEY DAVID L
(Director) |
M | Common Stock | A | 30000 | $1.74 - $1.74 | $52,200 |
2024-04-10 | CORCEPT THERAPEUTICS INC | MAHONEY DAVID L
(Director) |
J | Common Stock | D | 55612 | $0.00 - $0.00 | $0 |
2024-04-10 | CORCEPT THERAPEUTICS INC | MAHONEY DAVID L
(Director) |
F | Common Stock | D | 2194 | $23.80 - $23.80 | $52,217 |
2024-04-04 | CORCEPT THERAPEUTICS INC | Lyon Joseph Douglas
(See Remarks) |
S | Common Stock | D | 5443 | $26.00 - $26.00 | $141,523 |
2024-04-04 | CORCEPT THERAPEUTICS INC | Lyon Joseph Douglas
(See Remarks) |
M | Common Stock | A | 5443 | $11.35 - $11.35 | $61,778 |
2024-04-01 | CORCEPT THERAPEUTICS INC | Swisher Daniel N JR
(Director) |
S | Common Stock | D | 2200 | $25.30 - $25.30 | $55,660 |
2024-04-01 | CORCEPT THERAPEUTICS INC | Swisher Daniel N JR
(Director) |
M | Common Stock | A | 2200 | $5.86 - $5.86 | $12,892 |
2024-03-27 | CORCEPT THERAPEUTICS INC | Maduck Sean
(See Remarks) |
S | Common Stock | D | 25953 | $25.01 - $25.01 | $649,024 |
2024-03-27 | CORCEPT THERAPEUTICS INC | Maduck Sean
(See Remarks) |
M | Common Stock | A | 25953 | $3.88 - $3.88 | $100,697 |
2024-03-18 | CORCEPT THERAPEUTICS INC | Maduck Sean
(See Remarks) |
S | Common Stock | D | 17219 | $25.00 - $25.00 | $430,475 |
2024-03-18 | CORCEPT THERAPEUTICS INC | Maduck Sean
(See Remarks) |
M | Common Stock | A | 27219 | $2.61 - $3.88 | $92,909 |
2024-03-01 | CORCEPT THERAPEUTICS INC | Lyon Joseph Douglas
(Chief Accounting Officer) |
F | Common Stock | D | 474 | $24.06 - $24.06 | $11,404 |
2024-03-01 | CORCEPT THERAPEUTICS INC | Lyon Joseph Douglas
(Chief Accounting Officer) |
A | Common Stock | A | 1014 | $24.06 - $24.06 | $12,198 |
2024-03-01 | CORCEPT THERAPEUTICS INC | Maduck Sean
(See Remarks) |
F | Common Stock | D | 505 | $24.06 - $24.06 | $12,150 |
2024-03-01 | CORCEPT THERAPEUTICS INC | Maduck Sean
(See Remarks) |
A | Common Stock | A | 1272 | $24.06 - $24.06 | $15,302 |
2024-03-01 | CORCEPT THERAPEUTICS INC | Guyer William
(Chief Development Officer) |
F | Common Stock | D | 604 | $24.06 - $24.06 | $14,532 |
2024-03-01 | CORCEPT THERAPEUTICS INC | Mokari Atabak
(Chief Financial Officer) |
F | Common Stock | D | 517 | $24.06 - $24.06 | $12,439 |
2024-03-01 | CORCEPT THERAPEUTICS INC | Mokari Atabak
(Chief Financial Officer) |
A | Common Stock | A | 1108 | $24.06 - $24.06 | $13,329 |
2024-03-01 | CORCEPT THERAPEUTICS INC | Swisher Daniel N JR
(Director) |
S | Common Stock | D | 2200 | $23.59 - $23.59 | $51,898 |
2024-03-01 | CORCEPT THERAPEUTICS INC | Swisher Daniel N JR
(Director) |
M | Common Stock | A | 2200 | $5.86 - $5.86 | $12,892 |
2024-03-01 | CORCEPT THERAPEUTICS INC | Robb Gary Charles
(Chief Business Officer) |
F | Common Stock | D | 656 | $24.06 - $24.06 | $15,783 |
2024-03-01 | CORCEPT THERAPEUTICS INC | Robb Gary Charles
(Chief Business Officer) |
A | Common Stock | A | 1394 | $24.06 - $24.06 | $16,769 |
2024-02-16 | CORCEPT THERAPEUTICS INC | Lyon Joseph Douglas
(Chief Accounting Officer) |
S | Common Stock | D | 1000 | $26.00 - $26.00 | $26,000 |
2024-02-16 | CORCEPT THERAPEUTICS INC | Lyon Joseph Douglas
(Chief Accounting Officer) |
M | Common Stock | A | 1000 | $11.35 - $11.35 | $11,350 |
2024-02-15 | CORCEPT THERAPEUTICS INC | Maduck Sean
(See Remarks) |
S | Common Stock | D | 31828 | $25.00 - $25.97 | $821,904 |
2024-02-15 | CORCEPT THERAPEUTICS INC | Maduck Sean
(See Remarks) |
M | Common Stock | A | 31828 | $3.29 - $3.88 | $113,469 |
2023-01-01 | CORCEPT THERAPEUTICS INC | BAKER G LEONARD JR
(Director) |
G | Common Stock | D | 0 | $0.00 - $0.00 | $0 |
2023-02-22 | CORCEPT THERAPEUTICS INC | Robb Gary Charles
(Chief Business Officer) |
G | Common Stock | D | 1175 | $0.00 - $0.00 | $0 |
2024-02-01 | CORCEPT THERAPEUTICS INC | Swisher Daniel N JR
(Director) |
S | Common Stock | D | 2200 | $22.00 - $22.00 | $48,400 |
2024-02-01 | CORCEPT THERAPEUTICS INC | Swisher Daniel N JR
(Director) |
M | Common Stock | A | 2200 | $5.86 - $5.86 | $12,892 |
2024-01-08 | CORCEPT THERAPEUTICS INC | Hunt Hazel
(Chief Scientific Officer) |
M | Common Stock | A | 50000 | $3.02 - $3.02 | $151,000 |
2024-01-08 | CORCEPT THERAPEUTICS INC | Hunt Hazel
(Chief Scientific Officer) |
F | Common Stock | D | 29792 | $27.46 - $27.46 | $818,088 |
2024-01-02 | CORCEPT THERAPEUTICS INC | Swisher Daniel N JR
(Director) |
S | Common Stock | D | 2200 | $22.11 - $22.11 | $48,642 |
2024-01-02 | CORCEPT THERAPEUTICS INC | Swisher Daniel N JR
(Director) |
M | Common Stock | A | 2200 | $5.86 - $5.86 | $12,892 |
2023-12-15 | CORCEPT THERAPEUTICS INC | Robb Gary Charles
(Chief Business Officer) |
G | Common Stock | D | 750 | $0.00 - $0.00 | $0 |
2023-12-08 | CORCEPT THERAPEUTICS INC | Robb Gary Charles
(Chief Business Officer) |
G | Common Stock | A | 1917 | $0.00 - $0.00 | $0 |
2023-12-05 | CORCEPT THERAPEUTICS INC | Robb Gary Charles
(Chief Business Officer) |
S | Common Stock | D | 7593 | $26.27 - $27.01 | $204,063 |
2023-12-04 | CORCEPT THERAPEUTICS INC | Robb Gary Charles
(Chief Business Officer) |
M | Common Stock | A | 15000 | $3.29 - $3.29 | $49,350 |
2023-12-04 | CORCEPT THERAPEUTICS INC | Robb Gary Charles
(Chief Business Officer) |
F | Common Stock | D | 8788 | $26.26 - $26.26 | $230,772 |
2023-12-01 | CORCEPT THERAPEUTICS INC | Swisher Daniel N JR
(Director) |
S | Common Stock | D | 2200 | $25.47 - $25.47 | $56,034 |
2023-12-01 | CORCEPT THERAPEUTICS INC | Swisher Daniel N JR
(Director) |
M | Common Stock | A | 2200 | $5.86 - $5.86 | $12,892 |
2023-11-13 | CORCEPT THERAPEUTICS INC | WILSON JAMES N
(Director) |
G | Common Stock | D | 3000 | $0.00 - $0.00 | $0 |
2023-11-01 | CORCEPT THERAPEUTICS INC | Lyon Joseph Douglas
(Chief Accounting Officer) |
S | Common Stock | D | 5000 | $28.08 - $28.11 | $140,519 |
2023-11-01 | CORCEPT THERAPEUTICS INC | Lyon Joseph Douglas
(Chief Accounting Officer) |
M | Common Stock | A | 5000 | $11.35 - $11.35 | $56,749 |
2023-11-01 | CORCEPT THERAPEUTICS INC | Maduck Sean
(See Remarks) |
S | Common Stock | D | 25000 | $28.08 - $28.11 | $702,599 |
2023-11-01 | CORCEPT THERAPEUTICS INC | Maduck Sean
(See Remarks) |
M | Common Stock | A | 25000 | $2.61 - $2.61 | $65,249 |
2023-11-01 | CORCEPT THERAPEUTICS INC | Swisher Daniel N JR
(Director) |
S | Common Stock | D | 2200 | $27.96 - $27.96 | $61,512 |
2023-11-01 | CORCEPT THERAPEUTICS INC | Swisher Daniel N JR
(Director) |
M | Common Stock | A | 2200 | $5.86 - $5.86 | $12,892 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |